Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures.
作者信息
Wendling D, Balblanc J-C, Brousse A, Lohse A, Lehuede G, Garbuio P, Toussirot E, Auge B, Jacques D
出版信息
Ann Rheum Dis. 2005 Sep;64(9):1378-9. doi: 10.1136/ard.2005.037762.
Abstract
摘要
相似文献
1
Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures.类风湿关节炎患者接受抗肿瘤坏死因子α治疗时的手术：一项关于50例手术的观察性研究
Ann Rheum Dis. 2005 Sep;64(9):1378-9. doi: 10.1136/ard.2005.037762.
2
Neutropenia while receiving anti-tumour necrosis factor treatment for rheumatoid arthritis.类风湿关节炎患者在接受抗肿瘤坏死因子治疗时出现中性粒细胞减少症。
Ann Rheum Dis. 2006 Dec;65(12):1678-9. doi: 10.1136/ard.2006.056176.
3
Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications?肿瘤坏死因子-α 阻滞剂治疗类风湿关节炎患者关节手术后的并发症和特征：围手术期中断肿瘤坏死因子-α 阻滞剂是否会降低并发症？
Rheumatology (Oxford). 2010 Feb;49(2):341-7. doi: 10.1093/rheumatology/kep376. Epub 2009 Dec 4.
4
Guillain-Barré syndrome in a patient receiving anti-tumour necrosis factor alpha for rheumatoid arthritis: a case report and discussion of literature.一名类风湿关节炎患者在接受抗肿瘤坏死因子α治疗时发生吉兰-巴雷综合征：病例报告及文献讨论
Ann Rheum Dis. 2008 Apr;67(4):575-6. doi: 10.1136/ard.2005.043208.
5
Disease modifying treatment and elective surgery in rheumatoid arthritis: the need for more data.类风湿关节炎的病情改善治疗与择期手术：需要更多数据。
Ann Rheum Dis. 2004 May;63(5):602-3. doi: 10.1136/ard.2003.017640.
6
Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers.在接受肿瘤坏死因子α阻滞剂治疗的风湿性疾病患者中进行的127例外科手术的并发症发生率。
Clin Exp Rheumatol. 2007 May-Jun;25(3):430-6.
7
Tumour necrosis factor alpha antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery.肿瘤坏死因子α拮抗剂与择期骨科手术的炎性关节病患者术后早期并发症
Ann Rheum Dis. 2005 Apr;64(4):650-1. doi: 10.1136/ard.2004.028365.
8
Primary nasal tuberculosis during anti-tumour necrosis factor alpha treatment of a patient with rheumatoid arthritis.类风湿关节炎患者在接受抗肿瘤坏死因子α治疗期间发生的原发性鼻结核
Scand J Infect Dis. 2013 Dec;45(12):957-60. doi: 10.3109/00365548.2013.818246. Epub 2013 Aug 19.
9
Comment on: Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications?关于以下内容的评论：接受肿瘤坏死因子-α阻滞剂治疗的类风湿关节炎患者关节手术后的并发症及特征：围手术期中断肿瘤坏死因子-α阻滞剂治疗是否能减少并发症？
Rheumatology (Oxford). 2010 Jun;49(6):1209; author reply 1210. doi: 10.1093/rheumatology/keq068. Epub 2010 Mar 17.
10
Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications.类风湿关节炎患者接受抗肿瘤坏死因子治疗相关脱髓鞘并发症时肿瘤坏死因子α受体超家族1A多发性硬化相关变体的频率
Ann Rheum Dis. 2018 Dec;77(12):1835-1836. doi: 10.1136/annrheumdis-2018-213183. Epub 2018 Jul 20.
引用本文的文献
1
A Meta-Analysis Examining the Effect of Perioperative Biologic Disease-Modifying Anti-Rheumatic Medications on Postoperative Wound Complications in Various Orthopedic Surgeries.一项Meta分析：探讨围手术期生物性改善病情抗风湿药物对各类骨科手术术后伤口并发症的影响
J Clin Med. 2024 Sep 18;13(18):5531. doi: 10.3390/jcm13185531.
2
Systemic Delivery of Anti-Integrin αL Antibodies Reduces Early Macrophage Recruitment, Inflammation, and Scar Formation in Murine Burn Wounds.抗整合素 αL 抗体的系统递送可减少小鼠烧伤创面早期巨噬细胞募集、炎症和瘢痕形成。
Adv Wound Care (New Rochelle). 2020 Dec;9(12):637-648. doi: 10.1089/wound.2019.1035. Epub 2020 Jan 28.
3
Pre-operative withholding of infliximab and the risk of infections after major surgery in patients with rheumatoid arthritis.类风湿关节炎患者术前停用英夫利昔单抗与大手术后感染风险。
Rheumatology (Oxford). 2020 Dec 1;59(12):3917-3926. doi: 10.1093/rheumatology/keaa291.
4
Anti-rheumatic treatment and prosthetic joint infection: an observational study in 494 elective hip and knee arthroplasties.抗风湿治疗与人工关节感染：494 例择期髋关节和膝关节置换术的观察性研究。
BMC Musculoskelet Disord. 2020 Jun 29;21(1):410. doi: 10.1186/s12891-020-03459-z.
5
Preoperative Evaluation and Management of Patients Receiving Biologic Therapies.接受生物疗法患者的术前评估与管理
Arch Bone Jt Surg. 2019 May;7(3):220-228.
6
Moderating effects of immunosuppressive medications and risk factors for post-operative joint infection following total joint arthroplasty in patients with rheumatoid arthritis or osteoarthritis.类风湿关节炎或骨关节炎患者全关节置换术后免疫抑制药物的调节作用及术后关节感染的危险因素
Semin Arthritis Rheum. 2017 Feb;46(4):423-429. doi: 10.1016/j.semarthrit.2016.08.011. Epub 2016 Aug 24.
7
Effect of Anti-TNF Antibodies on Clinical Response in Rheumatoid Arthritis Patients: A Meta-Analysis.抗TNF抗体对类风湿关节炎患者临床反应的影响：一项荟萃分析。
Biomed Res Int. 2016;2016:7185708. doi: 10.1155/2016/7185708. Epub 2016 Jul 31.
8
Increased risk of revision for infection in rheumatoid arthritis patients with total hip replacements.类风湿关节炎患者行全髋关节置换术后因感染而进行翻修手术的风险增加。
Acta Orthop. 2015;86(4):491-7. doi: 10.3109/17453674.2015.1017793. Epub 2015 Mar 17.
9
Perioperative management of the patient with rheumatoid arthritis.类风湿关节炎患者的围手术期管理
World J Orthop. 2014 Jul 18;5(3):283-91. doi: 10.5312/wjo.v5.i3.283.
10
[Recommendations of the German Society for Rheumatology on the perioperative approach under therapy with DMARDs and biologicals in inflammatory rheumatic diseases].[德国风湿病学会关于炎症性风湿疾病在使用改善病情抗风湿药和生物制剂治疗期间围手术期处理的建议]
Z Rheumatol. 2014 Feb;73(1):77-84. doi: 10.1007/s00393-013-1301-z.
Zotero 插件